2023 | | Identification of concealed cardiomyopathy using next-generation sequencing-based genetic testing in Korean patients initially diagnosed with idiopathic ventricular fibrillation | 황교승 |
2023 | | Sustained beneficial effect of β-blockers on clinical outcomes after discontinuation in patients with ST elevation myocardial infarction | 박진선, 서경우, 신준한, 윤명호, 최소연, 황교승 |
2023 | | Clinical and Genetic Features of Korean Inherited Arrhythmia Probands | 황교승 |
2023 | | Edoxaban treatment in atrial fibrillation in routine clinical care: One-year outcomes of the prospective observational ETNA-AF study in South Korean patients | 황교승 |
2023 | | Efficacy and Safety of Coadministered Ezetimibe–Rosuvastatin plus Telmisartan in South Korean Patients with Dyslipidemia and Hypertension: A Multicenter, Randomized, Double-Blind, Active-Controlled, Phase III Trial | 황교승 |
2022 | | Therapeutic implications of galectin-3 in patients with atrial fibrillation | 이광노, 황교승 |
2021 | | Long-term evaluation of sensing variability of a floating atrial dipole in a single‑lead defibrillator: The mechanistic basis of long-term stability of amplified atrial electrogram | 황교승 |
2021 | | Clinical events with edoxaban in south Korean and Taiwanese atrial fibrillation patients in routine clinical practice | 황교승 |
2020 | | Managing Nonagenarians with Acute Myocardial Infarction: Invasive versus Conservative Treatment | 박진선, 서경우, 신준한, 양형모, 윤명호, 임홍석, 최병주, 최소연, 탁승제, 황교승 |
2020 | | Usefulness of the trans-stent fractional flow reserve gradient for predicting clinical outcomes | 서경우, 양형모, 윤명호, 임홍석, 최병주, 최소연, 탁승제, 황교승 |
2019 | | Lipid-Core Plaque Assessed by Near-Infrared Spectroscopy and Procedure Related Microvascular Injury | 서경우, 양형모, 윤명호, 임홍석, 최병주, 최소연, 탁승제, 황교승 |
2019 | | Impact of new-onset diabetes on clinical outcomes after ST segment-elevated myocardial infarction | 박진선, 서경우, 서지연, 신준한, 양형모, 윤명호, 임홍석, 최병주, 최소연, 탁승제, 황교승 |
2019 | | Status of international normalized ratio control and treatment patterns in patients with nonvalvular atrial fibrillation taking vitamin K antagonist with or without antiplatelet therapy: Results from KORAFII registry | 황교승 |
2019 | | Visit-to-visit systolic blood pressure variability in patients with ST-elevation myocardial infarction predicts long-term cardiovascular outcomes | 박진선, 서경우, 신준한, 양형모, 윤명호, 임홍석, 최병주, 최소연, 탁승제, 황교승 |
2018 | | Efficacy and Safety of Ezetimibe and Rosuvastatin Combination Therapy Versus Those of Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia | 황교승 |
2018 | | Myocardial Mass Contributes to the Discrepancy Between Anatomic Stenosis Severity Assessed by Intravascular Ultrasound and Fractional Flow Reserve in Intermediate Lesions of the Coronary Artery | 박진선, 서경우, 신준한, 양형모, 윤명호, 임홍석, 최병주, 최소연, 탁승제, 황교승 |
2018 | | Comparison of efficacy and safety between two different irbesartan, generic vs branded, in the treatment of Korean patients with mild-to-moderate hypertension: an 8-week, multicenter, randomized, open-label, Phase IV clinical study | 황교승 |
2018 | | Importance of prognostic value of neutrophil to lymphocyte ratio in patients with ST-elevation myocardial infarction | 박진선, 서경우, 신준한, 윤명호, 최병주, 최소연, 탁승제, 황교승 |
2018 | | Quality of Anticoagulation and Treatment Satisfaction in Patients with Non-Valvular Atrial Fibrillation Treated with Vitamin K Antagonist: Result from the KORean Atrial Fibrillation Investigation II | 황교승 |
2018 | | Intravascular ultrasound characteristics in patients with intermediate coronary lesions and borderline fractional flow reserve measurements | 서경우, 양형모, 윤명호, 임홍석, 최병주, 최소연, 탁승제, 황교승 |